CD44 and neoplasm: Thus, in pancreatic cancer, the mouse strains used to date do not appear to affect the frequency of tumor initiation, further supporting the idea that CD24/CD44 cells in ALDHhigh and ALDHlow populations are unlikely to contribute to tumor initiation in our studies.